Patellar Tendinopathy
Conditions
Keywords
Patellar tendinopathy, Kinesiophobia, Shock wave therapy, Sensorimotor function
Brief summary
Patellar tendinopathy (PT) is a commonly used term for the clinical manifestation of patellar tendon pain and functional limitation with multifactorial etiology. It occurs in both athletes and general population in all age groups. It is often characterized as an overuse injury resulting from chronic failure of the healing response that is not strictly linked to inflammatory or degenerative processes.
Detailed description
Once enrolled, participants were examined by a physiotherapist, and received the first application of ESWT (week 0). At weekly intervals, they received three more applications and on the day of the last application (week 3), a control clinical examination was performed. In the 12th-week follow-up after the last application week 15), a final examination including joint position sense, balance and kinesiophobia evaluation was performed.
Interventions
DEVICEExtracorporeal Shockwave Therapy
The low-energy focused ESWT was applied using the BTL-6000 FSWT device with piezoelectric generator and a coupling pad which modulates penetration depth to 0-35 mm. The setting was chosen based on ISMST guidelines (https://shockwavether apy.org). Energy flux density varied between 0.14 and 0.18 mJ/ mm2 due to patient tolerance, frequency was set at 8 Hz. A total of 2000 shocks were applied semi-statically to the most defined pathological area in the patellar tendon followed by2000 shocks dynamically to the quadriceps muscle.
Sponsors
Ahmed Alshimy
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
15 Years to 18 Years
Healthy volunteers
No
Inclusion criteria
* Has patellar tendon pain, which limits (at least in part) the quality of normal daily. * Has clinical manifestation of PT (pain and impaired function) confirmed by a clinician. * Has symptoms only in one leg, the other one is asymptomatic. * Normal BMI.
Exclusion criteria
* Any contraindication for ESWT is present (according to the International Society for Medical Shockwave Treatment \[ISMST\] consensus at https://shockwavetherapy.org). * They were aware of any symptomatic mechanical tendon damage in the past (e.g. partial or complete rupture in relation to the injury), neurological, oncological, or systemic disease (e.g. neuropathy, lupus or rheumatic arthritis) coexists * They were already treated for PT elsewhere up to 3 months prior to the study (e.g. platelet- rich plasma therapy, physiotherapy incl. resistance training or ESWT).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Digital inclinometer | 4 months |
| Tampa scale for Kinesiophobia | 4 months |
| Biodex balance system (overall stability index) | 4 months |
| Biodex balance system (Anteroposterior) | 4 months |
| Biodex balance system (Mediolateral) | 4 months |
Countries
Egypt
Outcome results
None listed